HighTower Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

HighTower Advisors’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-67,484	Closed	-$171K	–	4113
2023 Q4	$171K	Buy	67,484 +2,500	+4%	+$5.82K	﹤0.01%	3057
2023 Q3	$156K	Hold	64,984	–	–	﹤0.01%	3000
2023 Q2	$151K	Buy	64,984 +1,482	+2%	+$4.18K	﹤0.01%	2965
2023 Q1	$163K	Sell	63,502 -428,300	-87%	-$1.23M	﹤0.01%	2823
2022 Q4	$1.23M	Sell	491,802 -87,333	-15%	-$244K	﹤0.01%	1561
2022 Q3	$1.67M	Buy	579,135 +162,057	+39%	+$682K	﹤0.01%	1341
2022 Q2	$1.88M	Buy	417,078 +173,028	+71%	+$1.03M	﹤0.01%	1299
2022 Q1	$1.96M	Buy	244,050 +229,500	+1,577%	+$2.02M	﹤0.01%	1385
2021 Q4	$170K	Buy	+14,550	New	+$174K	﹤0.01%	2823

HighTower Advisors's SLGC Position: Q1 2024 in Review

HighTower Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 67,484 shares — an estimated $171K sold.

HighTower Advisors first reported a position in SLGC in Q4 2021 and held it in 9 quarters. The position peaked at $1.96M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

HighTower Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
HighTower Advisors sold 67,484 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $171K.
HighTower Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
HighTower Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $1.96M in Q1 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.